SWM
REGN icon

SHP Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

SHP Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Buy
57
+7
+14% +$4.76K ﹤0.01% 627
2026
Q1 		$38.9K Buy
50
+16
+47% +$12.2K ﹤0.01% 553
2025
Q4 		$26.5K Buy
+34
New +$23.1K ﹤0.01% 619

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SHP Wealth Management's REGN Position: Q2 2026 in Review

SHP Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, buying an estimated $4.76K and bringing the position to 57 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

SHP Wealth Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $38.9K in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • SHP Wealth Management held 57 shares of Regeneron Pharmaceuticals worth $35.5K as of Q2 2026.
  • SHP Wealth Management bought 7 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.76K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #627 holding.
  • SHP Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • SHP Wealth Management's Regeneron Pharmaceuticals position peaked at $38.9K in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.